SYK — what changed in the latest 10-Q
A section-by-section comparison of SYK's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-11 vs the prior 10-Q · 2025-10-31
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +129 | −175 | ~13 | 107 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 4 |
| Controls & procedures | Text added/removed | 0 | −1 | ~2 | 4 |
| Risk factors | Some risk factors updated | +118 | 0 | 0 | 2 |
| Other information | Text added/removed | +15 | 0 | 0 | 5 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-11
Stryker Corporation ("we" or the "Company") is a global leader in
medical technologies and, together with our customers, we are
driven to make healthcare better. We offer innovative products
that help improve patient and healthcare outcomes. Alongside
our customers around the world, we impact more than 150 million
Text removed vs the prior filing · source: 10-Q · 2025-10-31
Stryker is a global leader in medical technologies and, together
with our customers, we are driven to make healthcare better. We
disposable products (Medical), minimally invasive products for
products for traditional brain and open skull based surgical
procedures; orthobiologic and biosurgery products, including
Controls & procedures
Text removed vs the prior filing · source: 10-Q · 2025-10-31
amended) on September 30, 2025. Based on that evaluation, the
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-11
10-K for 2025, except for updates to the following risk factors:
addition, we rely on networks and services, including internet
sites, cloud and software-as-a-service solutions, data hosting and
processing facilities and tools and other hardware, software
(including open-source software) and technical applications and
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-11
On February 24, 2026 Spencer Stiles, our President and Chief
Operating Officer, adopted a trading plan intended to satisfy the
Exchange Act for the sale of shares of Stryker common stock.
The plan terminates on the earlier of the close of trading on April
to be sold under the plan is sold, subject to early termination for
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice